The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for MR-107A-02, an investigational fast-acting oral formulation of meloxicam, for the ...

Pain scales are tools for people to describe the level of pain they experience. Healthcare workers can also use pain scale charts to assess patients. There are several different pain scales, each with ...

NSAIDs, ketamine, and mid- to high-potency opioids reduced acute pediatric pain, but effects were modest NSAIDs provided the greatest benefit and the least harm Systematic review and meta-analysis ...

Editor’s Note (1/31/25): The U.S. Food and Drug Administration has approved the novel nonopioid medication suzetrigine for acute pain. That pain ranges from moderate to severe. The drug was tested in ...